Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 3
2011 1
2012 2
2013 1
2014 3
2015 5
2016 2
2017 2
2018 1
2019 3
2020 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Harnessing NK Cell Checkpoint-Modulating Immunotherapies.
Chauhan SKS, Koehl U, Kloess S. Chauhan SKS, et al. Among authors: kloess s. Cancers (Basel). 2020 Jul 6;12(7):1807. doi: 10.3390/cancers12071807. Cancers (Basel). 2020. PMID: 32640575 Free PMC article. Review.
CAR-Expressing Natural Killer Cells for Cancer Retargeting.
Kloess S, Kretschmer A, Stahl L, Fricke S, Koehl U. Kloess S, et al. Transfus Med Hemother. 2019 Feb;46(1):4-13. doi: 10.1159/000495771. Epub 2019 Feb 5. Transfus Med Hemother. 2019. PMID: 31244577 Free PMC article. Review.
CAR-NK Cells Targeting HER1 (EGFR) Show Efficient Anti-Tumor Activity against Head and Neck Squamous Cell Carcinoma (HNSCC).
Nowak J, Bentele M, Kutle I, Zimmermann K, Lühmann JL, Steinemann D, Kloess S, Koehl U, Roßberg W, Ahmed A, Schaudien D, Neubert L, Kamp JC, Kuehnel MP, Warnecke A, Schambach A, Morgan M. Nowak J, et al. Among authors: kloess s. Cancers (Basel). 2023 Jun 13;15(12):3169. doi: 10.3390/cancers15123169. Cancers (Basel). 2023. PMID: 37370779 Free PMC article.
Advantages and applications of CAR-expressing natural killer cells.
Glienke W, Esser R, Priesner C, Suerth JD, Schambach A, Wels WS, Grez M, Kloess S, Arseniev L, Koehl U. Glienke W, et al. Among authors: kloess s. Front Pharmacol. 2015 Feb 12;6:21. doi: 10.3389/fphar.2015.00021. eCollection 2015. Front Pharmacol. 2015. PMID: 25729364 Free PMC article. Review.
Preclinical Assessment of Suitable Natural Killer Cell Sources for Chimeric Antigen Receptor Natural Killer-Based "Off-the-Shelf" Acute Myeloid Leukemia Immunotherapies.
Kloess S, Oberschmidt O, Dahlke J, Vu XK, Neudoerfl C, Kloos A, Gardlowski T, Matthies N, Heuser M, Meyer J, Sauer M, Falk C, Koehl U, Schambach A, Morgan MA. Kloess S, et al. Hum Gene Ther. 2019 Apr;30(4):381-401. doi: 10.1089/hum.2018.247. Epub 2019 Mar 18. Hum Gene Ther. 2019. PMID: 30734584
Development of Automated Separation, Expansion, and Quality Control Protocols for Clinical-Scale Manufacturing of Primary Human NK Cells and Alpharetroviral Chimeric Antigen Receptor Engineering.
Oberschmidt O, Morgan M, Huppert V, Kessler J, Gardlowski T, Matthies N, Aleksandrova K, Arseniev L, Schambach A, Koehl U, Kloess S. Oberschmidt O, et al. Among authors: kloess s. Hum Gene Ther Methods. 2019 Jun;30(3):102-120. doi: 10.1089/hgtb.2019.039. Epub 2019 May 16. Hum Gene Ther Methods. 2019. PMID: 30997855 Free PMC article.
25 results